Error loading player: No playable sources found

Workshop II: Process

Date
January 22, 2024
This product is not available for individual purchase, but it is available as part of the following products:

Session Speakers:


Incorporation of Platform Based Approaches and Prior Knowledge Leveraging Into the Recently Revised ICH Q5A (R2) Guideline

Kathryn KingCDER, FDA


Power of Platform to Accelerate Therapies Beyond a Pandemic 

Ronan Kelly, Eli Lilly and Company 



Leveraging Platforms to Accelerate ADC Formulation and Drug Product Development

Karen Rutherford, Pfizer Inc.


Continuous Platform Improvement to Propel Drug Substance Development,

Heather Nunn, Amgen Inc. 


Related Products

Thumbnail for Workshop II: Microbial In-Use Studies and Closed System Transfer Devices
Workshop II: Microbial In-Use Studies and Closed System Transfer Devices
In-Use Studies Microbial Challenge Studies: Cross-Industry Efforts to Harmonize Strategies in Collaboration with Health Authorities
Thumbnail for Workshop I: Panel Discussion: Analytical
Workshop I: Panel Discussion: Analytical
Emily English,_ Cartesian Therapeutics, Inc…
Thumbnail for Workshop I: Analytical
Workshop I: Analytical
PLATFORM TECHNOLOGIES DESIGNATION PROGRAM: HIGHLIGHTS OF STATUTORY LANGUAGE